Mammalian parthenogenesis could not survive but aborted during mid-gestation, presumably because of lack of paternal gene expression. To understand the molecular mechanisms underlying the failure of parthenogenesis at early stages of development, we performed global gene expression profiling and functional analysis of parthenogenetic blastocysts in comparison with those of blastocysts from normally fertilized embryos. Parthenogenetic blastocysts exhibited changes in the expression of 749 genes, of which 214 had lower expression and 535 showed higher expressions than fertilized embryos using a minimal 1.8-fold change as a cutoff. Genes important for placenta development were decreased in their expression in parthenote blastocysts. Some maternally expressed genes were up-regulated and paternal-related genes were down-regulated. Moreover, aberrantly increased Wnt signaling and reduced mitogen-activated protein kinase (MAPK) signaling were associated with early parthenogenesis. The protein level of extracellular signal-regulated kinase 2 (ERK2) was low in parthenogenetic blastocysts compared with that of fertilized blastocysts 120 h after fertilization. 6-Bromoindirubin-3 ′ -oxime, a specific glycogen synthase kinase-3 (GSK-3) inhibitor, significantly decreased embryo hatching. The expression of several imprinted genes was altered in parthenote blastocysts. Gene expression also linked reduced expression of Xist to activation of X chromosome. Our findings suggest that failed X inactivation, aberrant imprinting, decreased ERK/MAPK signaling and possibly elevated Wnt signaling, and reduced expression of genes for placental development collectively may contribute to abnormal placenta formation and failed fetal development in parthenogenetic embryos.
Introduction
Genomic imprinting is an epigenetic mechanism by which certain autosomal genes are expressed from only one parental allele. Correct regulation of imprinted genes is essential for normal mammalian development (Morison et al., 2001) . The growth and survival of the fetus depends on a well-developed placenta, and placental development requires input from both paternally and maternally imprinted genes, suggesting that imprinted genes play a major role in placental and fetal development . Genomic imprinting is a barrier to parthenogenetic birth in mammals Sturm et al., 1994; Walsh et al., 1994; Kono, 2006) . Parthenogenetic embryos lack a paternal genome and fetal development fails around mid-gestation. The cause of this failure has been attributed to defective placentation McGrath and Solter, 1984) . Parthenogenetic development can be extended to term, though at extremely low efficiency, by manipulating the expression of two imprinted genes, Igf2 and H19 (Kono et al., 2004) . Although the function of the H19 RNA remains to be determined (Carr et al., 2006) , parthenotes with monoallelic H19 expression survive longer in gestation but have placentas with atrophia, necrosis and other defects .
More detailed morphological analysis of parthenogenetic embryos reveals that the failure of parthenotes to develop to term is due to abnormal proliferation and differentiation in both embryonic and extra-embryonic lineages (Sturm et al., 1994) . These data suggest that aberrant expression of imprinted genes may not fully account for failed parthenogenetic embryo development.
To further understand the molecular mechanisms underlying parthenogenesis, previous studies have used microarray to compare gene expression among embryonic day-9.5 parthenogenetic, androgenetic and normal fertilized embryos and placenta (Kobayashi et al., 2000; Mizuno et al., 2002; Nikaido et al., 2003) , because at this stage the outward differences are most apparent and because sufficient RNA can be obtained for microarray analysis. One study predicted more than 2000 transcripts as candidates for imprinting (Nikaido et al., 2003) . However, many of these were not related to imprinting (Ruf et al., 2006) . A large number of differentiation genes between parthenogenetic and androgenetic embryos are expressed from both chromosomes. Differences in gene expression between parthenogenetic and androgenetic embryos at day 9.5 may be caused by earlier disruption of imprinted genes, which later regulate the non-imprinted genes or may result from the impact of aberrant development.
The specification of two distinct cell lineages in the blastocyst, the trophectoderm (TE) and the inner cell mass (ICM), represents the earliest differentiation event in mammalian development (Lu et al., 2008; Ng et al., 2008; Hemberger et al., 2009) . Following embryo implantation around embryonic day 3.5-4.5 in mice, ICM cells differentiate into all tissue lineages of the adult in vivo, and can generate embryonic stem (ES) cells in vitro. TE cells contribute exclusively to the extra-embryonic tissues of the placenta in vivo and form trophoblast stem cells in vitro. During early development, parthenogenetic embryos derived from artificial activation of oocytes in mice do not differ from fertilized embryos, with similar rates of development and total cell number, similar ratios of ICM versus TE, and similar Oct4 expression in blastocysts (Liu et al., 2002 (Liu et al., , 2004 . When transferred into pseudopregnant mice some parthenogenetic blastocysts implant and develop for an additional 7-9 days (our unpublished data). Pre-implantation development in vivo morphologically also does not differ between parthenogenetic and fertilized embryos (Henery and Kaufman, 1992; Tada and Takagi, 1992) .
We investigated the similarities and differences in gene expression between parthenogenetic and fertilized embryos at the blastocyst stage to understand the molecular mechanisms underlying early parthenogenesis. Since advances in microarray technology have made it possible to reliably derive gene expression profiles from only a few cells (Hamatani et al., 2004; Wang et al., 2004) , we attempted for the first time to compare the global gene expression between parthenote blastocysts and blastocysts from fertilized embryos by microarray analysis ( Figure 1A) . We found that early parthenogenetic embryos differ substantially from fertilized embryos at the molecular level and that these differentially expressed genes are associated with aberrant placental and fetal development of parthenotes.
Results

Gene expression profiling and validation by real-time PCR
When evaluated by gene expression arrays, parthenogenetic embryos differed markedly from normally fertilized embryos at the blastocyst stage. Parthenogenetic blastocysts exhibited changes in the expression of 749 genes, of which 214 had lower expression and 535 showed higher expressions than fertilized embryos using a minimal 1.8-fold change as a cutoff (Supplemental Tables S1 and S2 ). Scatter plots were performed to visualize fold change between parthenogenetic blastocysts and fertilized blastocysts ( Figure 1B) . The raw microarray expression values were converted to heatmap to illustrate trends in the differential expression of genes ( Figure 1C) . The heatmap clusters indicate relative expression for triplicate experiments, illustrating that parthenote blastocysts differ markedly from fertilized blastocysts ( Figure 1D ). Of note, genes with low expression are not always accurately measured in microarray experiments, which can contribute to the overestimation of fold change and the accumulation of false positives. The vast majority of genes detected in this experiment are in the high expression category, where measurements are more accurate. Finally, a large number of transcripts disrupted in the parthenogenetic embryos remain uncharacterized. More than 100 transcripts from poorly characterized mouse genes exhibited differential expression in parthenogenetic embryos. Many of these are only identified by expressed sequence tag clones collected from early embryos.
We validated expression changes in a limited number of genes using quantitative real-time PCR assays with independent pools of embryos. We selected 16 genes from those showing significant differential expression in the microarray experiment. With genespecific primers (Supplemental Table S3 ), the PCR experiments replicated the microarray profiling for all 16 of the selected genes (Figure 2) , although fold changes differed somewhat between qPCR and microarray, which can be explained by different probes used for PCR and microarray. All eight genes that exhibited lower expression in parthenotes in the microarray experiment also showed decreased expression by qPCR ( Figure 2A ). The expression of Slc38a4 and Xist was considerably lower in parthenotes. Other eight genes showing higher expression in parthenogenetic blastocysts by the microarray analysis also exhibited increased expression by qPCR ( Figure 2B ). Although real-time qPCR analysis showed greater sensitivity than that of microarray experiments, the data obtained from the two methods showed the same direction of change in all genes studied by both methods. qPCR analysis confirms that the expression pattern of many genes changes in parthenotes compared with fertilized embryos even at the blastocyst stage.
Down-regulated genes in parthenote blastocysts
We identified 214 genes down-regulated or absent in parthenogenetic blastocysts (Supplemental Table S1 ). Some of these might have been expected, as parthenotes do not contain Y chromosomes or paternally imprinted genes. A few of the more notable changes are listed in Table 1 . In all cases genes transcribed from the Y chromosome were detected in the fertilized embryos, but not from parthenogenetic embryos. Five genes (Uty, Smcy/Jarid1d, Ddx3y/Dby, Usp9y and Eif2s3y) were decreased in parthenotes. In addition, an unannotated transcript (Probe: ID; 1446017_at; GenBank: BG071600), which may be transcribed from several locations on the Y chromosome, was lower in the parthenogenetic blastocysts. The expression of several imprinted, paternally expressed genes was much lower in parthenogenetic embryos. Expression of Peg3, Snrpn, Kcnq1ot1 and Slc38a4 appeared in fertilized embryos but not in parthenogenetic embryos. This provided a mechanism for identifying other possible paternally expressed genes. We looked specifically at all transcripts present in the zygotic embryos but absent in parthenotes. The Affymetrix probes that behaved this way were further examined to identify genes showing features of imprinting, such as CpG (methylated CG rich region connected by a phosphodiester bond) islands at the promoter site and clustering near other imprinted genes. We have identified 12 candidates for paternally expressed, potentially imprinted genes which are expressed at the blastocyst stage in fertilized embryos (Supplemental Table S4 ).
Many genes involved in placental development already were expressed in fertilized blastocysts and their expression greatly reduced in pre-implantation parthenogenetic blastocysts. Genes such as Slc38a4/Ata3, Epas1/HIF2a, Gab1, Plac9 and possibly a unique transcript variant of Ppap2b/Lpp3, were greatly reduced, if not absent, in parthenogenetic blastocysts ( Table 1) . HIF1a and HIF2a are essential for the determination of murine placental cell fates (Cowden Dahl et al., 2005) . Gab1 is a signal transduction adaptor that leads to placental defects in knockout animals (Itoh et al., 2000; Nishida and Hirano, 2003) . Plac9 is a placenta-specific gene with unknown function (Galaviz-Hernandez et al., 2003) and the transporters of the Slc38 gene family are implicated in the transport of neutral amino acids to the embryo via the placenta (Mizuno et al., 2002; Constancia et al., 2005) . Slc38a1, Slc38a2 and Slc38a4/ Ata3 are highly expressed in normal fertilized embryos, but absent or severely reduced in parthenotes. The genes Slc38a4/ Ata3 and Slc38a2 are known to be imprinted. It is possible that Slc38a1 also might be imprinted to control its expression in the placenta. Slc38a1 was one of the 12 potential imprinted genes we identified, as was Gab1.
Up-regulated genes in parthenote blastocysts
We identified 535 genes with increased expression in parthenote blastocysts (Supplemental Table S2 ). Transcripts enhanced in parthenotes include several maternally expressed genes, such as Tssc3/Phlda2, H19, Grb10/Meg1 and Cdkn1c ( Table 2) . Grb10/Meg1 was three times higher in parthenogenetic embryos in the microarray experiment, while H19 was three times higher in the microarray experiment and six times higher by qPCR. Tssc3/Phlda2/lpl expression was 2-23 times higher in parthenotes versus fertilized blastocysts. These genes are known to negatively regulate placenta growth. For example, maternally transcribed Tssc3/Phlda2 is expressed in extraembryonic tissues prior to gastrulation. Deletion of Tssc3 causes loss of imprinting and placental overgrowth (Dunwoodie and Beddington, 2002; Frank et al., 2002) . Grb10/Meg1 negatively regulates growth of both embryo and placenta (Miyoshi et al., 1998; Charalambous et al., 2003) and over expression of H19 leads to prolonged fetal development as well as placental defects . For each of these genes, higher than normal expression retards placental development, and we observed higher than normal expression in parthenote blastocysts. A few genes with increased expression in parthenotes may promote placental development. Plac1 (Cocchia et al., 2000) , Prss11/Htra1 (Nie et al., 2005) and Dusp9 (Saba-El- Leil et al., 2003; Christie et al., 2005) genes involved in trophoblast differentiation and placental growth, were 2-6-fold elevated in parthenogenetic blastocysts. The effect of increased expression for these genes is not easy to surmise, but these results illustrate that many genes involved in placental development are expressed prior to implantation.
The most notable aspect of genes up-regulated in parthenogenetic embryos was their unequal chromosomal distribution ( Figure 3A) . A significant proportion (124 genes or 25%) of the up-regulated genes identified in this study resided on the X chromosome ( Figure 3A) , where only one down-regulated Growth factor receptor bound protein 2-associated protein 1 NM_021356 45.6 Placenta labyrinth growth, MAPK signaling gene (Xist) was located. Unequal expression of genes from the X chromosome likely results from having two copies of the maternal X chromosome and no copies of inactivated, paternally inherited X chromosome (Panning and Jaenisch, 1998) . It is more likely that active X chromosome transcription contributes to the increased expression of X-related genes in parthenote blastocysts. The paternal X chromosome is inactivated early during development in normal female mouse embryos and remains inactivated in the placenta (Panning and Jaenisch, 1998; Heard et al., 2004; Okamoto et al., 2004) . This inactivation relies on the expression of Xist (Marahrens et al., 1998) and its antisense transcript Tsix (Lee, 2000) . Xist was the only X chromosomal gene showing reduced expression in the parthenogenetic blastocyst. Xist expression was about 1/10 the level found in fertilized embryos. We looked at all genes on the X chromosome that appeared to be expressed in fertilized blastocysts, and found that all exhibited higher expression levels in parthenotes, with most showing approximately a 2-fold increase compared with fertilized blastocysts ( Figure 3B ).
Functional analysis of differentially expressed genes associated with early parthenogenesis
We used Onto-Express and Pathway Express (ref. Materials and methods) to identify biological functions that might be influenced by the gene expression changes in parthenogenetic blastocysts. Many changes occurred in genes involved in signal transduction, regulation of transcription, cell cycle, cellular transport and development, indicating that many developmental mechanisms might be affected in parthenotes prior to implantation. Parthenote blastocysts had elevated expression of genes involved in cell differentiation, proteolysis, peptidolysis and protein amino acid phosphorylation (Supplemental Table S5) . Surprisingly, parthenogenetic blastocysts exhibited increased expression of nine genes involved in neuronal differentiation and development and six genes for heart-or muscle-specific differentiation. In contrast, few genes known to participate in differentiation for organogenesis were reduced in the parthenotes. It is possible that this represents a premature activation of differentiation pathways in the parthenote, or that the blastocyst expresses these genes at higher levels because the extra-embryonic tissues are not developing along the correct pathway in these embryos.
Pathway Express analysis illustrated several pathways that might be adversely affected in the parthenogenetic embryos (Figures 4 and 5) . Interestingly, the MAP kinase, and Wnt signaling involve extra-cellular communication, suggesting that methods of cell-to-cell communication may be changed early in parthenogenetic embryos. Indeed, cell -cell communication is known to be critical for embryonic development (Loebel et al., 2003) .
Decreased MAPK signaling pathway in parthenogenetic blastocysts
Many genes associated with ERK/MAPK signaling pathway showed altered expression in the parthenotes. This pathway is implicated in regulating cell growth and differentiation (Johnson and Vaillancourt, 1994) . This pathway, in turn, might be affected by a number of genes, including increased expression of fibroblast growth factor, platelet-derived growth factor, PAK1/2 and Map3k12, and decreased expression of fibroblast growth factor receptor, Gab1 and Map4k4. However, MKP (Dusp1/MKP-1, Dusp4/MKP-2 and Dusp9/MKP-4) were significantly up-regulated in parthenote blastocysts ( Figure 4A ). These enzymes dephosphorylate extracellular signal-regulated kinases (ERK), JNK and p38, inhibiting mitogen-activated protein kinase (MAPK) signaling (Dickinson et al., 2002; Sakaue et al., 2004; Chi et al., 2006) . Gab1 also was significantly down-regulated in parthenotes, which also could contribute to decreased ERK/MAPK signaling. In addition, Spred1 expression was up-regulated. Spred1, a novel Ras/MAPK inhibitor, was able to reduce the levels of the active forms of small GTPase protein Ras and Raf1 (King et al., 2005) . The gene expression mode indicated that MAPK signaling was inactive in parthenote embryos. Indeed, expression of ERK2 was significantly decreased in parthenote embryos compared with fertilized embryos, which was confirmed by qPCR ( Figure 4B ). Also, the protein level of ERK2 was low in parthenogenetic blastocysts compared with that of fertilized blastocysts 120 h after fertilization ( Figure 4C ), further confirming decreased ERK/MAPK signaling in parthenotes, albeit occurring 24 h later at the protein level.
Increased Wnt signaling pathway in parthenogenetic blastocysts
The Wnt signaling pathway appeared activated in parthenogenetic embryos ( Figure 5A ). The activators (cAMP dependent protein kinase, PKA and transcription factor, TCF) were increased in parthenotes compared with fertilized blastocysts. We have verified Dual specificity phosphatase 9 NM_029352 6.0 Placental organogenesis the expression changes in TCF7L2 by qPCR ( Figure 2B ). Wnt signaling has been implicated in the regulation of cell proliferation, apoptosis and cell fate (Wodarz and Nusse, 1998) . Wnt signaling also played a critical role in both initiating and patterning of the anterior -posterior axis, which precedes gastrulation during mouse embryonic development. We found remarkable differences in hatching between fertilized and parthenogenetic blastocysts. Fertilized embryos initiated hatching around 72 h and most showed obvious hatching by 96 h ( Figure 5B , Supplemental Video S1), whereas parthenogenetic blastocysts showed no signs of hatching at 72 h or even by 96 h, despite obvious expansion (Supplemental Video S2). The aberrant activation of the Wnt signaling pathway might be associated with the delayed hatching observed in parthenogenetic blastocysts. Indeed, fertilized embryos treated with 5 mM 6-bromoindirubin-3 ′ -oxime (BIO), a specific glycogen synthase kinase-3 (GSK-3) inhibitor that activates the Wnt signaling pathway (Sato et al., 2004) , significantly decreased hatching (19%, 20/106) compared with controls (92%, 87/95; Figure 5C ). These data show that aberrant activation of Wnt signaling pathway compromises the initial processes of blastocyst hatching.
Discussion
Early parthenogenetic embryos are morphologically similar to fertilized embryos, but they contain hundreds of differences in gene expression as early as day 3.5-4 of development. The alteration of such a large number of highly expressed genes in early embryos could disrupt many aspects of development, leading to the failure of parthenogenesis. Many of the alterations in gene expression found in parthenogenetic blastocysts could directly affect placental development. Imprinted genes influence placental development and function, consequently affecting all fetal growth through effects on fetal nutrition . Expression of genes previously reported to promote placental development, such as Slc38a4, HIF2a, Gab1 and Plac9, is reduced in parthenotes. Conversely, expression of genes reported to negatively regulate placental growth is increased in parthenogenetic blastocysts. Four of five maternally expressed imprinted genes showing increased expression in parthenotes (H19, Tssc3/Phlda2, Grb10/Meg1 and Cdkn1c) affect placental growth (see Angiolini et al., 2006) . Our analysis suggests that expression of several paternally expressed genes is higher in fertilized blastocysts than in parthenote blastocysts. Based on their gene expression profiles and genomic organization, the genes in Supplemental Table S4 may be imprinted, and expressed only from the paternal chromosome, thus leading to the reduced expression observed in the parthenogenetic embryos.
In addition to specific genes, we have identified two signal transduction pathways that are altered in parthenote blastocysts. Signaling via the ERK/MAPK pathway is essential for placental development, although it may be dispensable for fetal development (Rossant and Cross, 2001; Saba-El-Leil et al., 2003; Christie et al., 2005; Bissonauth et al., 2006) . Decreased ERK/ MAPK signaling at the blastocyst stage can contribute to defective placental development in parthenotes. Mutations in this signaling cascade lead to defects in the placental labyrinthine region (Rossant and Cross, 2001) . ERK2/MAPK function contributes to normal trophoblast development in the mouse, possibly controlling the proliferation of polar TE cells (Saba-El-Leil et al., 2003; Lu et al., 2008) . Expression and phosphorylation of ERK2 increase between Day 4 and 5 in fertilized embryos, but not in parthenogenetic embryos [in this work and also Chen et al. (2009)] , suggesting that in parthenotes this pathway is compromised prior to formation of placenta.
In contrast, the Wnt signaling pathway is up-regulated in parthenogenetic embryos compared with fertilized embryos. Expression of LPP3/Ppap2b, which has been proposed to activate the Wnt/TCF signaling pathway and interfere with the formation of the placenta and extra-embryonic vasculature (EscalanteAlcalde et al., 2003) is reduced in parthenotes. We show that aberrant activation of Wnt signaling pathway is associated with reduced hatching in parthenogenetic blastocysts, consistent with a previous finding that aberrant activation of b-catenin by LiCl, another GSK-3 inhibitor, also significantly inhibits blastocyst hatching . Further study of MAPK and Wnt pathway may have implications for understanding the hatching defects found in infertility clinics.
Mouse embryos preferentially inactivate the paternally derived X chromosome in extra-embryonic tissues (Takagi and Sasaki, 1975; Hadjantonakis et al., 2001; Okamoto and Heard, 2006) . Loss of Xist imprinting was found in parthenogenetic preimplantation embryos and failure to inactivate an X chromosome in extra-embryonic lineages contributes to the non-viability of parthenogenetic embryos (Mann and Lovell-Badge, 1988; Nesterova et al., 2001) . Parthenogenetic embryos do not contain paternal X chromosomes, so placental defects are not a consequence of failure to suppress paternal gene expression from the X chromosome. The presence of two maternal X chromosomes (X m X m ) might instead be associated with failure of parthenogenetic development that leads to early embryonic death (Shao and Takagi, 1990) . Embryonic lethality in parthenotes can be rescued by tetraploid embryos (Goto and Takagi, 1998 ), yet, we have transferred 190 parthenote embryos complemented by tetraploid embryos (Nagy et al., 1993; Eggan et al., 2002) and observed advanced developmental stages up to 17 days in gestation, but never full-term development (unpublished observation).
The gene expression profiling reported here further links reduced expression of Xist to extensive X chromosome activation in parthenote blastocysts. Our data indicate that X inactivation may not efficiently occur in the parthenogenetic embryo. Virtually every gene on the X chromosome is increased in expression in parthenotes relative to fertilized embryos, with an average increase of about 2-fold. Yet, Xist was the only X linked transcript with reduced expression in the parthenotes, roughly 1/10 the level observed in fertilized embryos. It is well established that male blastocysts are negative for Xist expression, whereas female blastocysts (X m X p ) actively produce the Xist RNA (Kay et al., 1993; Goto and Takagi, 2000; Kobayashi et al., 2006) . Our microarray and qPCR data suggest that the parthenogenetic embryo (X m X m ) is not able to produce enough Xist RNA to effectively inactivate one of the X chromosomes. X m X p fertilized embryos express much higher levels of Xist than XY embryos, in Aberrant MAPK and Wnt Signaling Pathways sharp contrast to our observation in parthenogenetic X m X m embryos where Xist is significantly reduced, in association with X activation. Consistently, PCR data also showed significantly reduced expression of Xist in parthenote (gynogenetic) blastocysts compared with androgenetic blastocysts (Latham and Rambhatla, 1995) . These data imply that some aspects of the paternally contributed X chromosome are responsible for initiating or perpetuating the Xist production, and thus for inactivation of the additional X chromosome.
ES cells normally originate from the ICM of blastocysts developed from fertilized embryos. Strikingly, parthenogenetic (p)ES cells also have been successfully derived from parthenogenetic blastocysts, despite the failed post-implantation development of the embryos (Allen et al., 1994; Szabo and Mann, 1994) . Our data also suggest why pES cells might be successfully propagated. The microarray profiling detected no differences in pluripotent stem cell markers, including Oct4, Nanog, Sox2 and Myc, between fertilized and parthenote blastocysts. Inhibition of MAPK signaling pathway promotes derivation and maintenance of ES cells in the pluripotent state (Burdon et al., 2002; Buehr and Smith, 2003; Liu et al., 2007) . Consistently, efficiency in the isolation of pES cells from parthenogenetic blastocysts with reduced MAPK signaling is higher than that of fES cells from fertilized blastocysts, and inhibition of MAPK signaling pathway by PD98059 facilitates derivation of fES cells (Chen et al., 2009 ).
ERK/MAPK activation has a pro-differentiation effect and is antagonistic to ES cell self-renewal (Burdon et al., 2002; Buehr and Smith, 2003; Meloche et al., 2004) , while modulation of Wnt signaling can maintain pluripotency and interfere with ES cell differentiation (Aubert et al., 2002; Kielman et al., 2002; Sato et al., 2004; Hao et al., 2006) . Increased X chromosome activation and reduced Xist expression in parthenotes also cooperate to prevent ES cell differentiation (Rastan and Robertson, 1985; Kay et al., 1993; Chaumeil et al., 2002) . Although genomic imprinting and aberrant gene expression affect embryonic development, ES cells isolated from blastocysts cultured in vitro could lead to normal gene expression in the ES cell lines (Brambrink et al., 2006) . Together, our data suggest that parthenogenetic ES cells can be efficiently derived from parthenote blastocysts (Chen et al., 2009) , consistent with the notion that decreased ERK/MAPK signaling, activated Wnt signaling and increased X chromosome activation in parthenote blastocysts favor derivation and maintenance of pES cells.
Our data are the first to describe in detail the earliest changes in gene imprinting and X chromosome activation-associated genes that are coupled with parthenogenesis. Further, the gene expression profiling data from the blastocyst stage of development provides a molecular explanation of why parthenogenesis in mammals produces defective placental but advanced fetal development. Remarkably, analysis of this microarray data also reveals previously unknown signaling pathways unique to early parthenogenesis. Parthenogenetic embryos fail at different stages during early and post-implantation development, suggesting that each embryo may fail for a different reason (Sturm et al., 1994) . Our comprehensive gene expression analysis suggests that in addition to failed X inactivation and aberrant expression of imprinted genes, decreased ERK/MAPK signaling and increased TCF/Wnt signaling may contribute to defective placenta formation and failed embryonic development. Parthenogenetic embryos or pES cells, therefore, may be amenable to experimental compensation to extend their development.
Materials and methods
Mice, oocytes and embryos B6C3F1 (C3H male × C57BL/6 female mice) female mice at 6 -10 weeks of age (Charles River Laboratory, Raleigh, NC, USA) were superovulated by injection of 5 IU pregnant mare's serum gonadotropin (eCG; Calbiochem, La Jolla, CA, USA) followed by 5 IU human chorionic gonadotropin (hCG) 46-48 h later. In some experiments, ICR outbred mice also were used. Oocytes enclosed in cumulus masses were collected from oviduct ampullae 14 h after hCG injection. Cumulus cells were removed by pipetting after brief incubation in 0.03% hyaluronidase prepared in potassium simplex optimized medium (KSOM) containing 14 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 4 mM sodium bicarbonate (HKSOM) (Lawitts and Biggers, 1993; Liu et al., 2002) . Oocytes were then washed and incubated in 50-ml droplets of pre-equilibrated KSOM supplemented with amino acids and 2.5 mM HEPES and covered with mineral oil pending further treatments. Oocyte and embryo cultures were carried out at 378C in a humidified atmosphere of 7% CO 2 in air.
Parthenogenetic embryos were produced by activation of oocytes with SrCl 2 and cytochalasin D for 4 h, and then cultured in KSOM as described previously (Liu et al., 2002 (Liu et al., , 2004 .
To obtain fertilized embryos, superovulated female mice were mated individually with B6C3F1 males of proven fertility soon after injection of 5 IU eCG. Successfully mated females were used for collecting zygotes (Day 0.5) 20-21 h after hCG injection. Zygotes surrounded by cumulus cells were released from the ampullae, and treated with 0.03% hyaluronidase prepared in HKSOM to remove the cumulus cells. Zygotes were washed and cultured in 50-ml droplets of pre-equilibrated KSOM, supplemented with amino acids, covered with mineral oil at 378C in a humidified atmosphere of 7% CO 2 in air. Early blastocysts were formed on Day 3.5 (70 -72 h in culture), and late expanded blastocysts on Day 4.5 (96 h in culture). We previously demonstrated that normal fertilized blastocysts derived from culture in vitro under this condition produced pregnancies and live pups comparable to those developed in vivo (Liu et al., 2000) . To minimize differences in developmental timing, parthenogenetically activated oocytes, with clear 'pronuclei' comparable in size to zygotic pronuclei, were identified after culture in vitro. Thus parthenogenetic blastocysts were harvested about 6 h later than fertilized blastocysts. Blastocysts were stored in RNAlater (Ambion Inc., Austin, TX, USA), pending RNA extraction.
Triplicate samples were prepared from these different types of embryos.
Microarray
After 96 h in culture approximately 30 parthenogenetic or fertilized blastocysts were pooled in triplicate experiments and total RNA extracted using the RNAqueous tm -MICRO kit (Ambion). RNA quality was assessed on the Agilent 2100 Bioanalyzer using a RNA 6000 PICO assay (Agilent Technologies, Amstelveen, The Netherlands). For each RNA sample, 10 ng was used as input for the GeneChip eukaryotic two-cycle procedure (Affymetrix Inc., Santa Clara, CA, USA). Briefly, 10 ng of total RNA from each sample was converted to double-strand cDNA using the Two-Cycle cDNA Synthesis kit and IVT amplification of cRNA performed with the MEGAscript T7 kit (Ambion). After cleanup of the cRNA, a second cDNA synthesis step was performed and subsequent biotin labeled cRNA made (GeneChip IVT labeling kit; Affymetrix). Biotin labeled cRNA was fragmented using the Sample Cleanup Module (Affymetrix). Fragmentation was checked on an Agilent 2100 Bioanalyzer using the RNA 6000 NANO assay (Agilent Technologies) and hybridized to the gene chip (Mouse Genome 430 2.0 array; Affymetrix) containing over 39000 transcripts (45101 probe-sets), as described in the Gene Chip Expression Analysis Technical Manual (Affymetrix).
Affymetrix data analysis
Hybridized arrays were scanned with a Gene Array Scanner (Affymetrix). Signal intensities were calculated and array comparisons performed with MAS 5.0. We compared the results from fertilized to parthenogenetic embryos. Only probe sets showing at least 1.8-fold change in independent triplicate experiments were retained in the final list. The detection call indicates whether a transcript was reliably detected (P, Present) or not (A, Absent). We then performed hierarchical clustering with the above differentiated genes using cluster software (version 3) and by applied mean centering and normalization of genes and arrays before average linkage clustering. Differentially expressed genes were classified by functional annotation using Onto-Express and Pathway-Express Tools (http:// vortex.cs.wayne.edu/ontoexpress/servlet/UserInfo, Intelligent Systems and Bioinformatics Laboratory, Department of Computer Science, Wayne State University, MI, USA) (Draghici et al., 2003) .
Quantitative real-time PCR
Twenty B6C3F1 fertilized and parthenogenetic blastocysts at 96 h in culture were washed twice in microdrops of RNase free water, then pipetted into 75 ml of RLT buffer with 10% b-mercaptoethanol as the first step toward isolation of total RNA with the RNeasy Micro Kit (74004, Qiagene). First-strand cDNA was synthesized using a synthesis kit (FSK-100 TOYOBO) with an oligo dT primer. Quantitative real-time PCRs were performed by ABI PRISM w 7900HT Sequence Detection System in triplicate on each sample using the following settings: denaturation at 958C for 10 min, followed by 40 cycles of 15 sec 958C, 30 sec annealing (temperature specific for each primer), 30 sec 728C extension. The total volume for each well was 25 ml and contained 12.5 ml of 2× SYBR green master mix (QPK-201 TOYOBO), 10.5 ml of sterilized water, 1 ml of cDNA and 1 ml of primer mix (Supplemental Table S3 ). All experiments included negative controls, with no cDNA for each primer pair. The DC t values were calculated using the SDS 2.0 software (ABI) and normalized to the expression level of the b-actin gene. The DDC t values were converted to fold change and plotted relative to the fertilized embryos arbitrarily set as 1. Significance was determined using analysis of variance (ANOVA) and Fisher post hoc least significant difference (PLSD) in the StatView software (SAS Institute, Cary, NC, USA) and P , 0.001.
Western blots
Fertilized and parthenote embryos (n ¼ 30) at 96 and 120 h in culture were collected in SDS sample buffer, heated to 1008C for 4.5 min, and frozen at 2208C until use. Total protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with a 4% stacking gel and 10% separating gel at 90 V, 0.5 h and 120 V, 2.5 h, respectively, and electrophoretically transferred onto nitrocellulose membranes (Gelmen, pore size 0.45 mm) for 2.5 h, 200 mA, at 48C, as described previously (Huo et al., 2004) . The nitrocellulose membrane with transferred proteins was washed in Tris electrophoresis buffers (TBS: 10 mM Tris, 150 mM NaCl, pH 7.4) twice and blocked in 5% skimmed milk in TBST (TBS containing 0.1% Tween-20) at 48C overnight. The blocked membrane was incubated with antibody to ERK (sc-154, Santa Cruz) for detection. The membrane was incubated with HRP-conjugated goat-anti-rabbit IgG (Jackson Immunoresearch Laboratories, Inc., PA, USA) diluted in TBST as the secondary antibody. Antibody binding was visualized with the enhanced chemiluminescence detection system according to the manufacturer's instructions (Amersham Pharmacia Biotech). As a negative control, the primary antibody was replaced with nonspecific rabbit IgG or mouse IgG.
Time lapse live imaging
After embryos were cultured in vitro for an appropriate time, three to four embryos were washed and transferred into 2 ml of HKSOM medium covered with mineral oil in 35-mm coated glass bottom microwell dishes (MatTek Corporation). The dishes were placed on a heating plate controlled by a temperature controller (Medical Systems Corp., Model: TC-202A) to maintain constant temperature at 378C. These embryos were imaged under a Zeiss inverted microscope using AxionVision LE software with time lapse imaging capability.
Statistical analysis
Each experiment was repeated at least three times. Comparison of means was carried out by ANOVA and Fisher PLSD using StatView software (SAS Institute). Percentages were transformed using an arcsine transformation. Significant difference was defined as P , 0.01.
Supplementary data
Supplementary data for this article are available online at journal of Molecular Cell Biology online.
